Skip to Content

Join the 'Prostate Cancer' group to help and get support from people like you.

Prostate Cancer News

Related terms: Cancer, Prostate, Carcinoma of Prostate

Should Prostate Cancer Screening Start Earlier for Black Men?

Posted 2 days 4 hours ago by Drugs.com

MONDAY, April 24, 2017 – With black men at higher risk of developing – and dying from – prostate cancer, some researchers believe these men merit their own race-based screening guidelines. It's known that incidence of prostate cancer is 60 percent higher among black men in the United States than among white men, said Ruth Etzioni, senior author of a new study. Moreover, their death rate from prostate cancer is more than twice as high, said Etzioni, who's with the Fred Hutchinson Cancer Research Center's division of public health sciences, in Seattle. The new study finds that prostate cancers in black men also tend to progress faster than in whites. Because of this, Etzioni and her colleagues believe black men should start discussing prostate cancer screening with their doctor in their 40s, rather than waiting until their 50s, which is what most guidelines recommend. "Screening ... Read more

Related support groups: Prostate Cancer, Diagnosis and Investigation, Body Imaging

PSA Testing Rates for Prostate Cancer Have Leveled Off

Posted 2 days 6 hours ago by Drugs.com

MONDAY, April 24, 2017 – Rates of prostate-specific antigen (PSA) screening have leveled off after declining for a number of years in the United States, American Cancer Society researchers report. The decline followed recommendations from the U.S. Preventive Services Task Force (USPSTF). In 2008, the USPSTF recommended against PSA screening for men aged 75 or older. Then, in 2012, the group recommended against PSA testing for men of all ages. But the American Cancer Society and other groups urge men 50 and older who have a long life expectancy to talk with their doctor and make a shared decision about PSA screening. According to previous research from the cancer society, PSA screening rates were about 38 percent for men aged 50 and older in 2010. By 2013, that number had dropped to 31 percent. In the new study, Stacey Fedewa, director of screening and risk factor surveillance at the ... Read more

Related support groups: Prostate Cancer, Diagnosis and Investigation

Black Americans' Cancer Rates Differ by Birthplace

Posted 13 days ago by Drugs.com

THURSDAY, April 13, 2017 – Cancer rates differ between African- and U.S.-born black Americans, a new study finds. "Typically, cancer occurrence among blacks in the United States is presented as one homogenous group, with no breakdown by country or region of birth," said study co-author Dr. Ahmedin Jemal, an American Cancer Society epidemiologist. "Our study shows that approach masks important potential differences that may be key to guiding cancer prevention programs for African-born black immigrants," Jemal added. The researchers analyzed 2000-2012 U.S. data to compare rates of the top 15 cancers in African-born blacks to U.S.-born blacks. Blacks born in sub-Sahara Africa had much higher rates of infection-related cancers (liver, stomach and Kaposi sarcoma) than U.S.-born blacks. They also had higher rates of blood cancers (leukemia and non-Hodgkin lymphoma), prostate cancer and ... Read more

Related support groups: Cancer, Prostate Cancer, Leukemia, Thyroid Cancer, Kaposi's Sarcoma

Many Docs Don't Discuss Prostate Cancer Screening Pros and Cons

Posted 15 days ago by Drugs.com

TUESDAY, April 11, 2017 – Fewer than one in three men screened with the PSA (prostate-specific antigen) test for prostate cancer talked about the risks and benefits of the test with their doctor. Those findings come as an influential United States Preventive Services Task Force (USPSTF) panel on Tuesday decided to loosen its recommendations on the PSA test. Now, the panel says discussion between a man and his doctor should guide decisions around getting the test. But researchers at Brown University say these discussions are still uncommon. "That only about a third of patients [in the study] reported having a discussion of advantages and disadvantages is an alarming statistic," study author Dr. George Turini III said in a news release from the Rhode Island university. Turini is a clinical instructor in medical science at the university's Warren Alpert Medical School. His team said an ... Read more

Related support groups: Prostate Cancer, Diagnosis and Investigation, Body Imaging

Updated Prostate Cancer Test Guidelines Now Stress Patient Choice

Posted 15 days ago by Drugs.com

TUESDAY, April 11, 2017 – In a significant shift, a key health advisory panel plans to soften its recommendation against prostate-specific antigen (PSA) screening for detecting prostate cancer. In 2012, the U.S. Preventive Services Task Force recommended that men no longer get their PSA tested. That recommendation was based on evidence that PSA screening resulted in overdiagnosis and unnecessary treatment that could leave men impotent and incontinent. Now, after reviewing follow-up evidence, the task force is recommending that men aged 55 to 69 have a discussion with their doctor about the pros and cons of PSA screening. For men aged 70 and older, the recommendation for no PSA screening remains in place. "There is probably a small benefit overall to screening," said task force chair Dr. Kirsten Bibbins-Domingo. She is a chair in medicine and a professor of medicine, epidemiology and ... Read more

Related support groups: Prostate Cancer, Diagnosis and Investigation, Body Imaging

'Cancer Profile' Is Changing for Americans With HIV

Posted 5 Apr 2017 by Drugs.com

WEDNESDAY, April 5, 2017 – As HIV becomes a lifetime disease instead of a killer, researchers say these patients will likely start to mirror other Americans when it comes to the kinds of cancers they develop. By 2030, the total number of cancers in HIV-positive people is expected to decline dramatically, as fewer patients develop tumors linked to a ravaged immune system, the new report suggested. Prostate, lung and liver cancer are predicted to become the most common cancers in this group, followed by anal cancer, which is linked to the sexually transmitted human papillomavirus (HPV). "They're starting to look more like people without HIV in a lot of ways, but the cancer risk will still be different," said Michael Silverberg, a research scientist with Kaiser Permanente Northern California. He was not involved in the study. In the early years of the AIDS epidemic, patients developed ... Read more

Related support groups: Cancer, HIV Infection, Prostate Cancer, Lung Cancer

Guys, a Good Night's Sleep Might Save Your Life

Posted 3 Apr 2017 by Drugs.com

MONDAY, April 3, 2017 – Adequate sleep isn't a luxury; it's essential. And for men, it might even mean the difference between life and death, a preliminary study suggests. Researchers found that men younger than 65 who slept just three to five hours a night were 55 percent more likely to develop fatal prostate cancer than those who got the recommended seven hours of shuteye nightly. And, six hours of sleep a night was linked to a 29 percent higher risk of prostate cancer death compared to seven hours. "If confirmed in other studies, these findings would contribute to evidence suggesting the importance of obtaining adequate sleep for better health," said lead study author Susan Gapstur, vice president of epidemiology at the American Cancer Society. However, more research is needed to better understand the biologic mechanisms, said Gapstur. For now, she considers the study "intriguing" ... Read more

Related support groups: Sleep Disorders, Insomnia, Fatigue, Prostate Cancer

Survival Continues to Improve for Most Cancers

Posted 31 Mar 2017 by Drugs.com

FRIDAY, March 31, 2017 – Overall cancer death rates in the United States continue to fall, but racial gaps persist, a new report says. Death rates fell between 2010 and 2014 for 11 of the 16 most common cancers in men and for 13 of the most common types in women, including lung, colon, prostate and breast cancers. However, death rates rose for cancers of the liver, pancreas and brain in men and for the liver and uterus in women. And improvements in cancer survival weren't equal for all Americans. "While this report found that five-year survival for most types of cancer improved among both blacks and whites over the past several decades, racial disparities for many common cancers have persisted, and they may have increased for prostate cancer and female breast cancer," said Dr. Lynne Penberthy. She's associate director of the U.S. National Cancer Institute's Surveillance Research ... Read more

Related support groups: Cancer, Breast Cancer, Prostate Cancer, Lung Cancer, Renal Cell Carcinoma, Colorectal Cancer, Non-Small Cell Lung Cancer, Breast Cancer, Metastatic, Brain Tumor, Melanoma, Skin Cancer, Pancreatic Cancer, Ovarian Cancer, Endometrial Cancer, Osteosarcoma, Small Cell Lung Cancer, Breast Cancer - Adjuvant, Cervical Cancer, Bladder Cancer, Melanoma - Metastatic

Is MRI the 'Mammography' of Prostate Cancer Screening?

Posted 27 Mar 2017 by Drugs.com

SATURDAY, March 25, 2017 – MRI screening might greatly reduce overdiagnosis and overtreatment of prostate cancer in older men, a preliminary study suggests. Compared to the current screening method, MRI can reduce overdiagnosis of prostate cancer by 50 percent, and unnecessary biopsies by 70 percent in men over 70, Dutch researchers reported Saturday at a conference in England. Prostate cancer is common in aging men, but it's often slow-growing and non-threatening. Screening sometimes begins with a blood test to measure the level of PSA (prostate specific antigen). If elevated, it might indicate cancer. So, the next step is a needle biopsy, where a doctor takes multiple samples from the prostate and has them tested for cancer. Because PSA testing is an inexact science, "the benefit of early prostate cancer detection with random biopsy generally does not outweigh the harm induced by ... Read more

Related support groups: Prostate Cancer, Diagnosis and Investigation

Helping Cancer Caregivers Help Themselves

Posted 22 Mar 2017 by Drugs.com

WEDNESDAY, March 22, 2017 – When people are diagnosed with cancer, it's easy to overlook the toll the disease also takes on their caregivers, say social workers who specialize in cancer care. Cancer can dramatically alter relationships, forcing parents to depend on their children, or independent people to rely on loved ones. Meanwhile, those who support cancer patients – such as spouses, partners, siblings, children or friends – tend to put their own needs on the back burner. Caregivers who keep their mind and body healthy, however, are able to provide better care for their loved ones, advise Lauren Kriegel and Autumn Banta, oncology social workers at Rutgers Cancer Institute of New Jersey. Finding the time and energy to take care of yourself may seem difficult while caring for someone with cancer, Kriegel and Banta pointed out in a Rutgers news release. However, there are ways ... Read more

Related support groups: Anxiety and Stress, Cancer, Breast Cancer, Prostate Cancer, Lung Cancer, Colorectal Cancer

Family History of Colon Cancer Calls for Earlier Screening

Posted 21 Mar 2017 by Drugs.com

TUESDAY, March 21, 2017 – If you've got a family history of colon or rectal cancers, you probably need to start screening for these conditions before you turn 50, a cancer expert says. People with a close relative who has had colon or rectal cancer have a greater risk of being diagnosed with these cancers too, said Dr. Walter Koltun, chief of colon and rectal surgery at the Penn State Health Hershey Medical Center in a hospital news release. "A significant portion of the population does have those risk factors," Koltun said. "And their risk goes up significantly depending on who has been affected." If more than one close relative has had colon or rectal cancer, your risk of getting such a cancer is 12 times greater, he added. People who are diagnosed with colon or rectal cancers at a young age are more likely to have a genetic trait that could increase their risk for the disease. ... Read more

Related support groups: Cancer, Breast Cancer, Crohn's Disease, Colonoscopy, Prostate Cancer, Colorectal Cancer, Inflammatory Bowel Disease, History - Radiation Therapy

Prostate Cancer Treatments Have Varying Side Effects, Study Shows

Posted 21 Mar 2017 by Drugs.com

TUESDAY, March 21, 2017 – The long-term side effects of different prostate cancer treatments vary – and knowing that may help men decide which one is right for them. That's the conclusion of two new studies published March 21 in the Journal of the American Medical Association. Both followed men who had early stage prostate cancer treated with "modern" approaches – including the latest surgical and radiation techniques. And both found that side effects sometimes persisted for up to three years. The specifics, however, varied. Many men had surgery to remove the prostate. Overall, they tended to have greater declines in their sexual function, versus men who chose radiation or "active surveillance." They were also more prone to urinary incontinence. On the other hand, men treated with radiation typically had more problems with bowel function. If they also received hormonal therapy, they ... Read more

Related support groups: Urinary Tract Infection, Bladder Infection, Prostate Cancer, Casodex, Bicalutamide, Xtandi, Danazol, Danocrine, Flutamide, Nilutamide, History - Radiation Therapy, Nilandron, Enzalutamide, Eulexin

Another Study Ties Obesity to Certain Cancers

Posted 1 Mar 2017 by Drugs.com

WEDNESDAY, March 1, 2017 – Carrying extra weight increases the risk of a number of cancers, a new review reports. Additional pounds appear to particularly influence the risk of cancers related to the digestive organs or those driven by hormonal abnormalities, according to the review's European authors. The evidence is so strong at this point that important organizations such as the International Agency for Research on Cancer describe "excess body weight as an important cause of cancers," said Susan Gapstur. She's vice president of epidemiology at the American Cancer Society. The new evidence review was led by Maria Kyrgiou, of Imperial College London's Department of Surgery and Cancer. The review found that a jump in a person's body mass index (BMI) of 5 was associated with a higher cancer risk in the esophagus, bone marrow, biliary tract system, pancreas and kidneys. BMI is a rough ... Read more

Related support groups: Obesity, Cancer, Breast Cancer, Weight Loss, Prostate Cancer, Renal Cell Carcinoma, Colorectal Cancer, Pancreatic Cancer, Ovarian Cancer, Endometrial Cancer, Stomach Cancer, Gastric Cancer, Wilms' Tumor, Solid Tumors, Peritoneal Cancer, Insulinoma, Giant Cell Tumor of Bone, Neoplasm of Bone

Cancer Isn't 'One Size Fits All' for Hispanics

Posted 21 Feb 2017 by Drugs.com

TUESDAY, Feb. 21, 2017 – Cancer death rates can vary widely between different Hispanic ethnic groups in the United States, a new study finds. "Hispanic populations are all different, reflecting their country of origin, cultural experiences and socioeconomic status," said study author Dr. Paulo Pinheiro, an associate professor of epidemiology at the University of Nevada, Las Vegas. "If we can detect the differences among them, we can more easily identify public health strategies that could decrease their cancer risk and improve health outcomes," he explained. In the study, Pinheiro's team analyzed 2008-2012 health data from Florida. The researchers said this is the only state with statistically significant representation from all major Hispanic ethnic groups: Cuban, Puerto Rican, Mexican, Central American, Dominican and South American. While cancer is the leading cause of death among ... Read more

Related support groups: Cancer, Hepatitis C, Prostate Cancer, Hepatocellular Carcinoma, Hepatic Tumor

Low-Fat Meal May Boost Costly Cancer Drug

Posted 17 Feb 2017 by Drugs.com

FRIDAY, Feb. 17, 2017 – Eating a low-fat meal when taking an expensive prostate cancer drug can cut the cost of the drug by three-quarters, a new study indicates. "We know this drug [Zytiga] is absorbed much more efficiently when taken with food," said study author Dr. Russell Szmulewitz, an assistant professor of medicine at the University of Chicago. "It's inefficient, even wasteful, to take this medicine while fasting, which is how the drug's label says to take it," he noted in a university news release. But, Szmulewitz cautioned that patients shouldn't start experimenting with drug doses on their own. "This was a relatively small study, too small to show with confidence that the lower dose is as effective. It gives us preliminary, but far from definitive, evidence. Physicians should use their discretion, based on patient needs," he advised. Zytiga (abiraterone acetate) costs more ... Read more

Related support groups: Benign Prostatic Hyperplasia (BPH), Prostate Cancer, Prostatitis, Zytiga, Prostate Tumor - Benign

Page 1 2 3 ... Next

Ask a Question

Further Information

Related Condition Support Groups

Cancer

Related Drug Support Groups

estradiol, Lupron, Premarin, ethinyl estradiol, Estrace, Lupron Depot, Zoladex, Zytiga, Estradiol Patch, view more... Casodex, Eligard, Taxotere, Cenestin, Enjuvia, bicalutamide, Xtandi, cyclophosphamide, capecitabine, degarelix, flax, leuprolide, Trelstar, Provenge, Menest, docetaxel, abiraterone, Vantas, Xofigo, goserelin, Progynova, Firmagon, conjugated estrogens, Trelstar LA, Supprelin LA, Flax Seed Oil, Trelstar Depot, flutamide, Thais, Sandrena, cabazitaxel, triptorelin, Premarin Intravenous, esterified estrogens, Jevtana, Lupron Depot 11.25 mg, nilutamide, sipuleucel-t, radium 223 dichloride, Cytadren, Delestrogen, Viadur, histrelin, mitoxantrone, Estratab, Nilandron, Novantrone, abarelix, Zoladex 3-Month, diethylstilbestrol, Docefrez, estramustine, Stilphostrol, Thaissept, Progynova TS, aminoglutethimide, Valergen, Eulexin, Estinyl, Zumenon, Emcyt, Systen, Plenaxis, Provames, Oromone, Primogyn Depot, enzalutamide